13th Edition of International Conference on Neurology and Brain Disorders
October 19-21, 2026
Brain Tumors and Neuro-Oncology
Brain tumors and neuro-oncology are integral to addressing the complexities of primary and secondary brain cancers. This specialized field encompasses a range of treatment options, from surgery and radiation therapy to cutting-edge drug therapies and clinical trials exploring new drug combinations. Researchers are focused on overcoming the challenges posed by the blood-brain barrier to deliver effective treatments. With the advent of immunotherapy, CAR-T cell therapies, and personalized genetic profiling, the landscape of neuro-oncology is rapidly changing. The development of non-invasive diagnostic tools and predictive models is also helping clinicians better assess tumor behavior and patient prognosis. This research is instrumental in improving long-term outcomes and offering hope to patients affected by malignant brain tumors.
Ken Ware
NeuroPhysics Therapy Institute and Research Centre, Australia
Yong Xiao Wang
Albany Medical College, United States
Joe Sam Robinson
Mercer University, United States
Daniel Curry
Texas Children’s Hospital, United States
Steven Benvenisti
Davis, Saperstein Salomon, PC, United States
Younok Dumortier Shin
OnusBio, United States
Jessica Marchant
Texas Woman's University, United StatesSubmit your abstract Today
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Narrative medicine: A communication therapy for the communication disorder of Functional Seizures (FS) [also known as Psychogenic Non-Epileptic Seizures (PNES)]
Robert B Slocum, University of Kentucky HealthCare, United States
Title : Compromised psychophysical orientation to the vertical gravitational constant and its role in the emergence of complex neurological and mental disorders
Ken Ware, NeuroPhysics Therapy Institute and Research Centre, Australia
Title :
Ursula Abu Nahla, Hebron University, State of Palestine
Title : The efficacy and safety of Rimegepant every other day as preventive treatment for migraine: A systematic review and meta-analysis of randomized controlled trials
Abdalmajed Alqsair, King Saud bin Abdulaziz University for Health Sciences, Saudi Arabia
Title : Rewiring recovery: Effect of repetitive transcranial magnetic stimulation on neuropsychological outcomes following mild to moderate traumatic brain injury
Kumari Shaloo, All India Institute of Medical Sciences Raebareli, India